Swine Respiratory Disease
The Food and Drug Administration (FDA) has granted approval to Bayer HealthCare LLC, Animal Health for Baytril 100 (enrofloxacin) Injectable for treatment and control of swine respiratory disease (SRD) caused by Mycoplasma pneumonia (M. hyo) and Bordetella bronchiseptica. “M. hyo causes Mycoplasmal pneumonia of swine or enzootic pneumonia throughout the world and can become problematic if left untreated,” says Andy Holtkamp, Bayer senior veterinarian, technical services. “These recent FDA approvals for Baytril 100 to treat and control SRD associated with M. hyo and B. bronchiseptica now provide swine producers and veterinarians a powerful tool to treat and control six major swine pathogens.” The others include Actinobacillus pleuropneumonia, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis. Baytril 100 can be used as an effective treatment tool in pigs at eight to 12 weeks in finishing and as a health management tool to control SRD in the nursery and farrowing barn. To learn more, call (800) 422-9874 or visit www.Baytril100.com.